| ACSM | American College of Sports Medicine |
| AIC | Akaike information criterion |
| BIC | Bayesian information criterion |
| BMI | Body mass index |
| CI | Confidence interval |
| CLIA | Chemiluminescent immunoassay |
| CON | Control group |
| E1 | Estrone |
| E2 | Estradiol |
| ELISA | Enzyme-linked immunosorbent assay |
| EXP | Experimental group |
| Free E2 | Free estradiol |
| GC–MS | Gas chromatography–mass spectrometry |
| GRADE | Grading of Recommendations Assessment, Development, and Evaluation |
| HRmax | Maximum heart rate |
| HRR | Heart rate reserve |
| IEMA | Immunoenzymometric assay |
| I2 | I-squared statistic |
| MD | Mean difference |
| NR | Not reported |
| PICO | Population, Intervention, Comparator, and Outcome |
| PICOS | Population, Intervention, Comparator, Outcome, and Study Design |
| PI | Prediction interval |
| PCOS | Polycystic ovary syndrome |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROSPERO | International Prospective Register of Systematic Reviews |
| RCT | Randomized controlled trial |
| REML | Restricted maximum likelihood |
| RIA | Radioimmunoassay |
| RoB 2 | Risk of Bias 2 |
| SD | Standard deviation |
| SE | Standard error |
| SHBG | Sex-hormone-binding globulin |
| SMD | Standardized mean difference |
| TFM | Total fat mass |
| UHPLC–MS/MS | Ultra-high-performance liquid chromatography–tandem mass spectrometry |
| UPLC–MS/MS | Ultra-performance liquid chromatography–tandem mass spectrometry |
| VO2max | Maximal oxygen uptake |
| WC | Waist circumference |